This brand name is authorized in Austria, Estonia, Spain, Finland, Croatia, Ireland, Italy, Lithuania, Netherlands, Poland, Romania, United Kingdom
The drug KISPLYX contains one active pharmaceutical ingredient (API):
|
1
Lenvatinib
UNII 3J78384F61 - LENVATINIB MESYLATE
|
|
Lenvatinib is a receptor tyrosine kinase (RTK) inhibitor that selectively inhibits the kinase activities of vascular endothelial growth factor (VEGF) receptors VEGFR1 (FLT1), VEGFR2 (KDR), and VEGFR3 (FLT4), in addition to other proangiogenic and oncogenic pathway-related RTKs including fibroblast growth factor (FGF) receptors FGFR1, 2, 3, and 4, the platelet derived growth factor (PDGF) receptor PDGFRα, KIT, and RET. |
Below package inserts are available for further reading:
| Title | Information Source | Document Type | |
|---|---|---|---|
| KISPLYX Hard capsule | Medicines & Healthcare Products Regulatory Agency (GB) | MPI, EU: SmPC |
This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:
| ATC code | Group title | Classification |
|---|---|---|
| L01EX08 | L Antineoplastic and immunomodulating agents → L01 Antineoplastic agents → L01E Protein kinase inhibitors → L01EX Other protein kinase inhibitors | |
This drug has been assigned below unique identifiers within the countries it is being marketed:
| Country | Identification scheme | Identifier(s) |
|---|---|---|
| Country: EE | Ravimiamet | Identifier(s): 1728378, 1728389, 1821787, 1821798, 1821800, 1821811 |
| Country: ES | Centro de información online de medicamentos de la AEMPS | Identifier(s): 1161128001, 1161128002 |
| Country: FI | Lääkealan turvallisuus- ja kehittämiskeskus | Identifier(s): 453579, 467073 |
| Country: GB | Medicines & Healthcare Products Regulatory Agency | Identifier(s): 335615, 335617 |
| Country: IT | Agenzia del Farmaco | Identifier(s): 045060011, 045060023, 045060035, 045060047, 045060050, 045060062 |
| Country: LT | Valstybinė vaistų kontrolės tarnyba | Identifier(s): 1080867, 1080868, 1088910, 1088911, 1088912, 1088913 |
| Country: NL | Z-Index G-Standaard, PRK | Identifier(s): 133256, 133299 |
| Country: PL | Rejestru Produktów Leczniczych | Identifier(s): 100377486, 100377492 |
| Country: RO | Agenția Națională a Medicamentului și a Dispozitivelor Medicale | Identifier(s): W68099001, W68099002, W68099003, W68100001, W68100002, W68100003 |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
